BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33515899)

  • 1. Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re,
    Wang J; Makris G; Kuchuk M; Radford L; Gallazzi F; Lewis MR; Jurisson SS; Hennkens HM
    Nucl Med Biol; 2021; 94-95():46-52. PubMed ID: 33515899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor targeting with hydrophilic [
    Makris G; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
    Nucl Med Biol; 2019 Apr; 71():39-46. PubMed ID: 31129499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOTA and NODAGA [
    Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
    Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of a
    Radford L; Gallazzi F; Watkinson L; Carmack T; Berendzen A; Lewis MR; Jurisson SS; Papagiannopoulou D; Hennkens HM
    Nucl Med Biol; 2017 Apr; 47():4-9. PubMed ID: 28043006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the
    H A Kankanamalage P; Hoerres R; Ho KV; Anderson CJ; Gallazzi F; Hennkens HM
    Nucl Med Biol; 2022; 108-109():1-9. PubMed ID: 35144046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Characterization, and In Vitro Evaluation of New (99m)Tc/Re(V)-Cyclized Octreotide Analogues: An Experimental and Computational Approach.
    Li Y; Ma L; Gaddam V; Gallazzi F; Hennkens HM; Harmata M; Lewis MR; Deakyne CA; Jurisson SS
    Inorg Chem; 2016 Feb; 55(3):1124-33. PubMed ID: 26789775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivatives.
    Bigott-Hennkens HM; Dannoon SF; Noll SM; Ruthengael VC; Jurisson SS; Lewis MR
    Nucl Med Biol; 2011 May; 38(4):549-55. PubMed ID: 21531292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of Re/
    Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
    Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Preclinical Evaluation of
    Makris G; Bandari RP; Kuchuk M; Jurisson SS; Smith CJ; Hennkens HM
    Mol Imaging Biol; 2021 Feb; 23(1):52-61. PubMed ID: 32886303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro structure-activity relationship of Re-cyclized octreotide analogues.
    Dannoon SF; Bigott-Hennkens HM; Ma L; Gallazzi F; Lewis MR; Jurisson SS
    Nucl Med Biol; 2010 Jul; 37(5):527-37. PubMed ID: 20610157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides.
    Sanders VA; Iskhakov D; Abdel-Atti D; Devany M; Neary MC; Czerwinski KR; Francesconi LC
    Nucl Med Biol; 2019; 68-69():1-13. PubMed ID: 30578134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma targeting with [
    Carta D; Salvarese N; Morellato N; Gao F; Sihver W; Pietzsch HJ; Biondi B; Ruzza P; Refosco F; Carpanese D; Rosato A; Bolzati C
    Nucl Med Biol; 2016 Dec; 43(12):788-801. PubMed ID: 27694057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting.
    Kim WH; Kim CG; Kim MH; Kim DW; Park CR; Park JY; Lee YS; Youn H; Kang KW; Jeong JM; Chung JK
    Ann Nucl Med; 2016 Jun; 30(5):369-79. PubMed ID: 26993818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.
    Goins B; Bao A; Phillips WT
    Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
    Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
    Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Versatile synthetic approach to new bifunctional chelating agents tailor made for labeling with the fac-[M(CO)(3)](+) core (M = Tc, (99m)Tc, Re): synthesis, in vitro, and in vivo behavior of the model complex [M(APPA)(CO)(3)] (APPA = [(5-amino-pentyl)-pyridin-2-yl-methyl-amino]-acetic acid).
    Stichelberger A; Waibel R; Dumas C; Schubiger PA; Schibli R
    Nucl Med Biol; 2003 Jul; 30(5):465-70. PubMed ID: 12831983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.
    De K; Banerjee I; Misra M
    Amino Acids; 2015 Jun; 47(6):1135-53. PubMed ID: 25743164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P.
    Smilkov K; Janevik E; Guerrini R; Pasquali M; Boschi A; Uccelli L; Di Domenico G; Duatti A
    Appl Radiat Isot; 2014 Sep; 92():25-31. PubMed ID: 24973465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal His-Tag Design for Efficient [
    Williams JD; Kampmeier F; Badar A; Howland K; Cooper MS; Mullen GED; Blower PJ
    Bioconjug Chem; 2021 Jul; 32(7):1242-1254. PubMed ID: 33241692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Backbone metal-cyclization: a novel approach for simultaneous peptide cyclization and radiolabeling. Application to the combinatorial synthesis of rhenium-cyclic somatostatin analogs.
    Fridkin G; Bonasera TA; Litman P; Gilon C
    Nucl Med Biol; 2005 Jan; 32(1):39-50. PubMed ID: 15691660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.